MétaCan
Menu
Back to cohort
Record W4415696134 · doi:10.1016/j.jacadv.2025.102276

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial

2025· article· en· W4415696134 on OpenAlexaff
Aranya Punithan, Ehsan Ghamarian, Daniela Grothe, Kim A. Connelly, Bruce Neal, Alanna Weisman, David Z.I. Cherney, Filio Billia, Jacob A. Udell

Bibliographic record

VenueJACC Advances · 2025
Typearticle
Languageen
FieldMedicine
TopicDiabetes Treatment and Management
Canadian institutionsTed Rogers Centre for Heart ResearchToronto Rehabilitation InstituteOccupational Cancer Research CentreLunenfeld-Tanenbaum Research InstituteSt. Michael's HospitalToronto General HospitalUniversity Health NetworkWomen's College Hospital
FundersJanssen Research and Development
KeywordsCanagliflozinDiabetes mellitusClinical trialDiseaseMEDLINE

Abstract

fetched live from OpenAlex

BACKGROUND: The CANVAS (Canagliflozin Cardiovascular Assessment Study) trial provided the opportunity to determine the utility of measuring cardiorenal biomarkers, such as fibroblast growth factor 23 (FGF-23) and high-sensitivity C-reactive protein (hsCRP) levels for determining risk prediction and treatment response to sodium glucose co-transporter 2 inhibitor therapy in patients with type 2 diabetes mellitus. OBJECTIVES: The prognostic value of these biomarkers for predicting adverse cardiovascular (CV) outcomes and treatment response was assessed. METHODS: Of 4,330, 3,188 (73.6%) participants had available longitudinal biomarker samples. The association between FGF-23 and hsCRP with composite CV death or hospitalization for heart failure (HHF), HHF, CV death, and major adverse CV events were assessed using multivariable Cox proportional hazard models adjusted for clinical risk factors, and markers of cardiac and renal injury. Event rates by randomized treatment assignment were calculated for FGF-23 and hsCRP after assignment to a "low-risk" (quartiles [Q] 1-3) or "high-risk" (Q4) group. Multimarker risk assessment was done by stratifying participants by both FGF-23 and hsCRP quartiles to create 4 risk groups. RESULTS: When compared with Q1, FGF-23 levels in Q4 were significantly associated with CV death/HHF (HR: 1.65; 95% CI: 1.15-2.40; P = 0.008) and HHF (HR: 1.96; 95% CI: 1.04-3.69; P = 0.037) whereas hsCRP levels in Q4 were significantly associated with CV death (HR: 1.78; 95% CI: 1.16-2.73; P = 0.008) and major adverse CV events (HR: 1.35; 95% CI: 1.02-1.78; P = 0.038) in adjusted analyses. There was consistent effect of canagliflozin vs placebo across high- and low-risk groups (P-interactions ≥0.30). CONCLUSIONS: FGF-23 and hsCRP are biomarkers associated with increased CV risk, but these markers did not identify participants who preferentially benefited from treatment with canagliflozin.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.789
Threshold uncertainty score0.194

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.258
Teacher spread0.250 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJACC AdvancesSame topicDiabetes Treatment and ManagementFrench-language works237,207